Literature DB >> 2538833

Human immunodeficiency virus tat-activated expression of poliovirus protein 2A inhibits mRNA translation.

X H Sun1, D Baltimore.   

Abstract

To study the effect of poliovirus protein 2A on cellular RNA translation, the tat control system of human immunodeficiency virus (HIV) was used. Protein 2A was expressed from a plasmid construct (pHIV/2A) incorporating the HIV long terminal repeat. Protein synthesis was measured by using chloramphenicol acetyltransferase as a reporter gene driven by the Rous sarcoma virus long terminal repeat. When HIV/2A was cotransfected with the reporter, addition of a tat-producing plasmid caused at least a 50-fold drop in chloramphenicol acetyltransferase synthesis. A HeLa cell line carrying HIV/2A was established. In it, tat expression caused more than a 10-fold drop in chloramphenicol acetyltransferase synthesis from the reporter plasmid. Furthermore, 2A induction by tat caused cleavage of the cellular translation factor P220, a part of eukaryotic translation initiation factor 4F. Thus protein 2A can, by itself, carry out the inhibition of cellular protein synthesis characteristic of a poliovirus infection. Also, the HIV tat activation provides a very effective method to control gene expression in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538833      PMCID: PMC286867          DOI: 10.1073/pnas.86.7.2143

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  The positive and negative transcriptional regulation of the Drosophila Gapdh-2 gene.

Authors:  X H Sun; J T Lis; R Wu
Journal:  Genes Dev       Date:  1988-06       Impact factor: 11.361

2.  mRNA cap binding proteins: essential factors for initiating translation.

Authors:  A J Shatkin
Journal:  Cell       Date:  1985-02       Impact factor: 41.582

3.  Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome.

Authors:  V R Racaniello; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

4.  The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.

Authors:  C M Gorman; G T Merlino; M C Willingham; I Pastan; B H Howard
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

5.  Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat.

Authors:  J Sodroski; C Rosen; F Wong-Staal; S Z Salahuddin; M Popovic; S Arya; R C Gallo; W A Haseltine
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

6.  A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein.

Authors:  H Toyoda; M J Nicklin; M G Murray; C W Anderson; J J Dunn; F W Studier; E Wimmer
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

7.  Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex.

Authors:  D Etchison; S C Milburn; I Edery; N Sonenberg; J W Hershey
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

8.  Proteolytic processing of poliovirus polypeptides: antibodies to polypeptide P3-7c inhibit cleavage at glutamine-glycine pairs.

Authors:  R Hanecak; B L Semler; C W Anderson; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

9.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

10.  Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells.

Authors:  C V Hall; P E Jacob; G M Ringold; F Lee
Journal:  J Mol Appl Genet       Date:  1983
View more
  24 in total

1.  Relationship of eukaryotic initiation factor 3 to poliovirus-induced p220 cleavage activity.

Authors:  E E Wyckoff; R E Lloyd; E Ehrenfeld
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

2.  Proteinase trapping: screening for viral proteinase mutants by alpha complementation.

Authors:  H D Liebig; T Skern; M Luderer; W Sommergruber; D Blaas; E Kuechler
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

3.  Characterization of poliovirus 2A proteinase by mutational analysis: residues required for autocatalytic activity are essential for induction of cleavage of eukaryotic initiation factor 4F polypeptide p220.

Authors:  C U Hellen; M Fäcke; H G Kräusslich; C K Lee; E Wimmer
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  Defective RNA replication by poliovirus mutants deficient in 2A protease cleavage activity.

Authors:  S F Yu; P Benton; M Bovee; J Sessions; R E Lloyd
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

Review 5.  Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes.

Authors:  W G Dougherty; B L Semler
Journal:  Microbiol Rev       Date:  1993-12

6.  Eukaryotic initiation factor 3 is required for poliovirus 2A protease-induced cleavage of the p220 component of eukaryotic initiation factor 4F.

Authors:  E E Wyckoff; J W Hershey; E Ehrenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

7.  Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A.

Authors:  J E Jewell; L A Ball; R Rueckert
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

8.  Inhibition of human immunodeficiency virus replication by the herpes simplex virus virion host shutoff protein.

Authors:  T Hamouda; R McPhee; S C Hsia; G S Read; T C Holland; S R King
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

9.  Translation of the hepatitis B virus P gene by ribosomal scanning as an alternative to internal initiation.

Authors:  N Fouillot; S Tlouzeau; J M Rossignol; O Jean-Jean
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

10.  Blockade of human immunodeficiency virus type 1 production in CD4+ T cells by an intracellular CD4 expressed under control of the viral long terminal repeat.

Authors:  L Buonocore; J K Rose
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.